fbpx

Announcing MedTech Actuator Showcase 2022 Award Winners

At the recent MedTech Actuator Showcase, we joined ecosystem leaders to celebrate Asia Pacific’s next wave of early-stage MedTech, HealthTech and BioTech entrepreneurs – with four taking home prestigious awards.

About MedTech Actuator Entrepreneurs

Our changemakers are taking their innovations further and faster with MedTech Actuator programs. Eight teams took to the stage in Melbourne to pitch to the ecosystem and industry leaders, including the largest names in medical technology and the startup ecosystem.

Stepping into the spotlight were entrepreneurs from early-stage innovation programs including MedTech Actuator Origin Australia and Japan and MedTech Actuator’s flagship Accelerator program.

Award Winners

MinterEllison MedTech Actuator Origin 2022 Award: EN∀I

Dr Simone Mitchel, Partner at MinterEllison joined us to announce the MinterEllison MedTech Actuator Origin 2022 Award.

Congratulations to Amin Abbas from ENI on taking out this prestigious award after a highly competitive process and pitching at the finals. NAME was selected by the audience and judges as the winner out of four early-stage entrepreneurs who made it to the Origin finals.

EN∀I is improving endometriosis imaging by using ultrasound with inbuilt guidance and 3D reconstruction.

“We were really impressed with the pitches tonight and we decided to offer the winner another $10k in in-kind legal services. Congratulations, EN∀I”, – Dr Simone Mitchel, Partner, MinterEllison.

As the MinterEllison MedTech Actuator Origin 2022 Award winner, ENI receives an AUD$10K cash prize, over AUD$5K worth of in-kind support from MedTech Actuator, legal services from MinterEllison to the value of AUD$10K, as well as access to a fast-tracked entry into the MedTech Actuator Accelerator 2023. 

MinterEllison MedTech Actuator Origin 2022 Award winners: Team EN∀I with Buzz Palmer, CEO MedTech Actuator and Simone Mitchel, Partner Minter Ellison

Bupa MedTech Actuator Accelerator 2022 Award: Anura Medical

Gerald Marion, Chief Customer and Strategy Officer at Bupa Asia Pacific, joined us to present the Bupa MedTech Actuator Accelerator 2022 Award. 

“Congratulations to the winner – innovations require a lot of perseverance and it is a long journey to market”, – Gerald Marion, Chief Customer and Strategy Officer, Bupa Asia Pacific.

The MedTech Actuator Accelerator supports founders in taking their innovation from Seed to Series A. Embedded in the MedTech Actuator ecosystem, startups radically advance their technology development, raise pre-seed capital, gain critical business and management skills and build a comprehensive commercialisation strategy. 

Congratulations to every founder on their relentless execution towards market success over these past six months – and to Phoebe Lewis from Anura Medical who took home the Bupa MedTech Actuator Accelerator 2022 Award, winning an AUD$10K cash prize.

Anura Medical helps people breathe better through continuous, wearable lung monitoring.  Founded by a team of engineers, doctors, and business consultants, Anura aims to create a new gold standard that will enable clinicians to treat breathing decline early and reduce health complications for people with lung disease.

Bupa MedTech Actuator Accelerator 2022 Award winner: Team Anura Medical with Buzz Palmer, CEO MedTech Actuator and Gerald Marion, Chief Customer and Strategy Officer, Bupa Asia Pacific.

MedTech Actuator People’s Choice 2022 Award: Vysum

Congratulations to MedTech Actuator Accelerator participant, Lorace Zhang from Vysum, for being selected for the MedTech Actuator People’s Choice 2022 Award.

MedTech Actuator Showcase guests from the innovation ecosystem – spanning investor groups and VCs, multinational corporations, hospitals, product development firms, universities, and research institutes – voted for their favourite pitch of the night, with Vysum taking home the prize.

This coveted vote of confidence went to Vysum for enabling easier eye drop delivery and glaucoma management. Vysum takes home an AUD$1K cash prize.

MedTech Actuator People’s Choice Award winner Lorace Zhang with Buzz Palmer, CEO MedTech Actuator and Rebecca Davies AO, MedTech Actuator Board Member

CROW Clinical Emerging Female Founder 2022 Award: April Van Der Kamp

In 2022, MedTech Actuator focused its efforts to help bridge the gaps for female and diverse founders to pursue entrepreneurship. In its first year event, Julie Von Grum, Director at CROW Clinical, joined to present the CROW Clinical Emerging Female Founder 2022 Award.

Now is the time for women to step up, to have a voice and confidence to go out start new ventures and raise capital”, Julie Von Grum, Director, CROW Clinical.

The CROW Clinical Emerging Female Founder 2022 Award was presented to April Van Der Kamp, CEO, DFU Solutions, acknowledging the impact and progress she has made as a leading female founder and CEO in the space. This award comes with an AUD$10K cash prize to recognise her contribution and efforts as an extraordinary female founder in our community. 

April started her journey with MedTech Actuator as a MedTech Actuator Menzies Scholar in 2021 before embarking on her journey in the MedTech Actuator Accelerator 2022 as the CEO of DFU Solutions, a BioTech startup developing safe, effective, convenient bacteriophage-based treatments for infected wound care.

Read more on April’s experience with the MedTech Actuator programs. Congratulations April, you inspire all the women in STEMM!

CROW Clinical Emerging Female Founder 2022 Award winner: April Van Der Kamp with Julie Von Grum, Director, CROW Clinical

It Takes A Village to Raise a MedTech Startup

The MedTech Actuator Showcase and the specialised acceleration model underpinning all of our programs would not be possible without the support of the innovation ecosystem. Read more about the evening and sponsors in the event brochure.

Special guests

Thank you to our distinguished Showcase guests for your support of our MedTech superheroes and the ecosystem:

  • Mr. Yasuyuki Murahashi – Director-General, JETRO Osaka
  • Rebecca Davies AO – MedTech Actuator Board Member; Director, Heart Foundation
  • Michelle Gallaher – MedTech Actuator Board member; CEO – Opyl

and others.

Showcase Sponsors

We would like to acknowledge our Gold and Bronze Sponsors for the MedTech Actuator Showcase – thank you to:

  • MinterEllison
  • Bupa
  • CROW Clinical
  • Hydrix
  • Biodesign Australia
MedTech Actuator Showcase 2022 Sponsors

Partners

We would also like to thank our Foundation and Product Development partners for their constant and continued support of both the MedTech Actuator and the ecosystem.

Friends and supporters

A very special shoutout to all our ecosystem friends and supporters. Without you, we would not be able to surround founders with the support they need to bring innovations to the patients and clinicians who need it most.

MedTech Actuator Accelerator applications are now open for 2023!

Do you have a medical innovation that you’re ready to bring to market? MedTech Actuator’s Accelerator is here to help and expression of interest is open. Over 12 months, the program will equip your team with the skills, network and resources needed to successfully navigate the commercialisation pathway. Become a part of MedTech Actuator’s next Accelerator cohort!

MedTech Actuator Origin and Accelerator are supported by the REDI initiative, powered by MTPConnect, funded by the MRFF and LaunchVic.

MedTech Actuator Origin Japan 2022 is sponsored by JETRO and co-organized with JETRO, OCCI and OBDA.

MedTech Actuator Showcase 2022 Lineup Announced

The annual MedTech Actuator Showcase brings together leaders and representatives from both the Australian and global health innovation ecosystems. The night will connect and celebrate the achievements, impact and progress of MedTech Actuator entrepreneurs and founders.

At the Showcase, MedTech Actuator Origin and Accelerator Cohort 7 startups will pitch to an audience of over 300 individuals to win $30,000+ in prizes across 4 categories. This event will also feature inspiring speeches from industry leaders, an insightful fireside chat with fast-growing MedTech startups, and opportunities to connect with ecosystem stakeholders.

Meet the four MedTech Actuator Accelerator startups pitching

MedTech Actuator’s flagship 12-month Accelerator program annually selects health startups investing up to  $200,000 in equity-based funding. The program encourages access to over 200 industry experts from across Australia and the globe, to accelerate their growth towards the market. 

At the showcase, hear from four Cohort 7 Accelerator startups innovating in phage therapy,  respiratory function, lumbar punctures and eye drop delivery.

Anura Medical Enabling preventative health care through innovative lung monitoring. 

DFU Solutions Improving outcomes for diabetic foot ulcer patients.

Vause Medical An accessible improvement to lumbar punctures in newborns

Vysum Enabling easier eye drop delivery and glaucoma management.

Meet the four MedTech Actuator Origin Finalists

MedTech Actuator Origin is an early-stage innovation program that turbocharges the development of emerging human health technologies and solutions across Australia and Asia-Pacific. 

32 Qualifying teams joined MedTech Actuator in Melbourne for an intensive sprint, where, over three days, they learned from industry experts, pressure tested their innovations, networked with a cohort, gained exposure to the startup ecosystem and health innovation, and pitched at the semi-finals. 4 Origin finalists innovating in dental, IVF,  dermatitis and endometriosis we selected in the semifinals.

AcuDent AcuDent is developing a medical device to revolutionise the detection of severe gum disease.

ENVI ENVI is improving endometriosis imaging by using ultrasound with inbuilt guidance and 3D reconstruction.

Innova IVF Innova IVF is creating simple, affordable chip technology to measure the energy of embryos in real time for IVF treatments.

Osaka Heat Cool Osaka Heat Cool helps to tackle the symptoms of Atopic Dermatitis (AD), allergies, and other skin diseases by stopping itchiness using thermal illusion on the skin.

At the Showcase, an exclusive black-tie event, 300+ senior representatives from 30+ key ecosystem organisations including governments, global corporations, universities, product development and startup support companies, and the inspiring health innovators, startup entrepreneurs and future stars of the Asia-Pacific health ecosystem will come together to showcase the MedTech startup ecosystem.

Join us at the MedTech Actuator Showcase and experience the power of the global MedTech ecosystem here in Melbourne. If you are interested in attending or sponsoring the event, please reach out to Matthew Frith, Chief Commercial Officer at MedTech Actuator.

MedTech Actuator Origin and Accelerator are supported by the REDI initiative, powered by MTPConnect, funded by the MRFF and LaunchVic.

Congratulations to the MedTech Actuator Origin 2022 Finalists!

Out of thirteen impressive startups that made it to the Origin Semi-final, MedTech Actuator is proud to announce four finalists moving forward to pitch at the MedTech Actuator Showcase in December.

After three days of intensive workshops, 10 emerging founders took to the stage to pitch in the 2022 MedTech Actuator Origin Semi-finals. Amongst the Australian founders, three Semi-Finalists from Origin Japan also joined the program in Melbourne, where they learned from industry experts, pressure-tested their innovations, and explored Australia’s startup ecosystem. 

Tackling some of the biggest challenges in healthcare, Finalists are innovating across dental, IVF, itching and endometriosis. Meet the MedTech Actuator Origin 2022 Finalists:

AcuDent

Team members: Liam Murray, Aaron Binns, Anna Dai, Ashwin Ho, Ivy Weng 

AcuDent is developing a medical device to revolutionise the detection of severe gum disease.

AcuDent’s device, the AcuProbe, applies computer vision within the oral environment to more efficiently and accurately conduct the work that current practice burdens the clinician to do manually. The device will ensure that proper diagnosis is achieved to avoid the occurrence of undetected periodontitis, ensuring patients receive the best possible care and dramatically reducing the chances of tooth loosening and tissue degradation – keeping everyone smiling longer.

ENVI 

Team members: Amin Abbas, Nay Minn, Dr Rizwan Jaipurwala, Frederick Lau, Joey Zhou, Steven Wong

ENVI is improving endometriosis imaging by using ultrasound with inbuilt guidance and 3D reconstruction.

ENVI is working on creating a device that can diagnose endometriosis using ultrasound. The device aims to reduce the diagnostic duration for endometriosis. This allows patients to receive an early diagnosis and hence access to early treatment.  Early diagnosis gives patients hope of slowing disease progression and reduces the harmful long-term risks associated with endometriosis, including its association with an increase in cancer risk. It also benefits GPs by reducing multiple patient visits with undifferentiated symptoms, improving the workflow of primary care staff and increasing patient satisfaction. 

Innova IVF

Team members: Dr Fabrizzio Horta, Dr Victor Cadarso, Prof Adrian Neild, Prof Beverley Vollenhoven, A/Prof Sally Catt

Innova IVF is creating simple, affordable chip technology to measure the energy of embryos in real time for IVF treatments.

Innova IVF aims to improve treatments for couples suffering from infertility worldwide. The most critical aspect of IVF treatments relies on the selection of embryos that will lead to a healthy live birth. Thus, the team aims to improve embryo selection by introducing novel non-invasive technology to measure the embryo’s energy in the form of metabolic activity.

Osaka Heat Cool

Team members: Kenzo Ibano, Kiyono Yoshikuni, Toru Sugahara, Kuichi Itoh, Katsunari Sato, Shintaro Izumi 

Osaka Heat Cool helps to tackle the symptoms of Atopic Dermatitis (AD), allergies, and other skin diseases by stopping itchiness using thermal illusion on the skin.

The team is solving the pain caused by itching using thermal illusion on the skin. Using an illusion called the thermal grill illusion, the device provides pain sensation by applying hot and cold sensations simultaneously. This pain sensation does not harm the skin, instead relieves the itch without scratching by nails.

We would like to thank our judges Dr Buzz Palmer, CEO of MedTech Actuator, Lorace Zhang, CEO at Vysum and MedTech Actuator Origin 2021 Winner, Laxmi Pun, Director of Early-stage Investments at Breakthrough Victoria, Shanna Lam, Project Officer at MedTech Actuator, and all community members for attending the MedTech Actuator Origin Semi-final and cheering on startups improving health outcomes.

The MedTech Actuator Origin Final will take place on Thursday, December 1 at the MedTech Actuator Showcase. At the Showcase, teams will have the chance to take home a $10K cash prize, over $5k worth of in-kind support and gain access to fast-tracked entry into MedTech Actuator Accelerator 2023.

What is next?

Preparations are now underway for a night-of-nights celebration at the MedTech Actuator Showcase, where all programs converge and the ecosystem – from across the Asia-Pacific – will come together to applaud the achievements, impact and progress of founders in health innovation. 

The MedTech Actuator Showcase will be held on Thursday, December 1 in Melbourne. If you are interested in purchasing a table or sponsoring a prize for this exclusive event, please reach out to Matthew Frith, Chief Commercial Officer at MedTech Actuator.

Stay in the loop by signing up for our newsletter below to get the latest updates on our programs and upcoming events.

MedTech Actuator Origin is supported by the REDI initiative, powered by MTPConnect, funded by the MRFF and LaunchVic.



Meet the 2022 MedTech Actuator Origin Cohort

Meet the 29 impressive teams from across Australia selected for the MedTech Actuator Origin 2022. 

Over three days in Melbourne, emerging founders will dive into workshops and industry-led mentoring to help them turbocharge projects and build a strategy to get their ideas to market. The Origin cohort will be joined by the impressive 2022 MedTech Actuator Menzies Scholars. During the sprint, teams will be introduced to topics such as idea validation, intellectual property, pitching, pathways to market, business models, navigating Australia’s healthcare ecosystem, and funding for early-stage ventures.

Ten projects from Australia will be selected to pitch at the Origin Semi-final, along with three Semi-finalist teams from Japan, to secure their place in the Origin Final at the MedTech Actuator Showcase in December.

The Origin 2022 participants include clinicians, researchers, and students working on MedTech, HealthTech and BioTech innovations that will improve the lives of patients and impact clinicians’ workflows. These solutions span key areas in human health, including dental, oncology, IVF, mental health, cardiology, allied health and more.

Welcome to our Origin 2022 participants

We are excited to announce the 29 teams participating in the MedTech Actuator Origin intensive sprint and competing in the Rapid Fire Round. 

  1. 2Hip4U | Kate Gallagher | Designing custom-made clothing that is practical and comfortable for babies with hip dysplasia.

  2. AcuDent | Liam Murray, Aaron Binns, Anna Dai, Ashwin Ho, Ivy Weng| Developing a medical device to revolutionise the detection of severe gum disease.

  3. AdraCard| Liam Mahony, Lachlan Timms | Creating an alternative to the EpiPen that eliminates the burden of carrying your adrenaline.

  4. C-arm Angio Screens patient positioning| Tim Stewart | Developing patient positioning devices for intraop use in the Cath Lab and Radiology.

  5. Ello Medical | Maria Borsaru, Daniel Malkinson, Kai Van Lieshout, Jeremy Yeh | A centralised directory for hospital staff to reach available clinicians.

  6. Innova IVF | Dr Fabrizzio Horta, Dr Victor Cadarso, Prof Adrian Neild, Prof Beverley Vollenhoven, A/Prof Sally Catt | Simple, affordable chip technology to measure the energy of embryos in real time for IVF treatments.

  7. La Petite Médicale | Rochelle De Silva, Laura Harman | Preventing extravasation injuries in pediatric patients through monitoring of cannula position.

  8. Frame Health | Melinda Wassell, Marcus Yeo | Efficient, compliant and helpful note-taking software for great clinical outcomes in allied health.

  9. Hormoneo | Hope Newman, Olivia Voulgaris | Developing a continuous hormone monitoring device to boost IVF success.

  10. TENSible | Sean James Dominique, Victoria Shi, Gwyneth Chua, Akanksha Agarwal, Josephine Wong | A non-invasive electrical stimulation device that offers personalised chronic back pain relief.

  11. LYF: Leveraging In Vitro Gametogenesis (IVG)| Jenna Hall | Helping people start families on a timeline best suited to them using stem cell technology.

  12. Sensure Medical |Brandon Qilin Chen, Aaron Khoo, Daniel Bertone, Michael Qu, Sophia Hsiang | A novel way to improve safety and accuracy of injections through tip localisation.

  13. Noodles Medical| Christopher Ong Yean Hong, Cindy Millenia Hidajat, Robert Jenny, Rochelle De Silva, Simone Di Bisceglie | A self-use device to treat and monitor chronic pelvic pain associated with the high-tone pelvic floor.

  14. Acegirl |Desiree D’Cruz | Empowering women to thrive at motherhood and life by creating discreet wearable breast pumps.

  15. SenSur | Fateme Akhlaghi Bagherjeri | Creating a non-invasive point-of-care multi-marker biosensor as a cardiac diagnostic tool.

  16. Vertere | Urwah Nawaz, Kate Leone, Jacky Cai, Vishal Uppal, Sharjeel Nawaz | An all-integrative lateral rotation mattress combined with machine learning automated prevention of pressure sore development. We are building a low-cost disability friendly mattress that provides PwD autonomy over their sleep

  17. EnVi | Amin Abbas | Endometriosis imaging using ultrasound with inbuilt guidance and 3D reconstruction

  18. OncoSure | Benjamin Arya, Oliver Cucanic | Detecting cancer early. In the comfort of your own home.

  19. Living Lateral Australia | Anita Nikora | It is self-operated & raises a patient from lying on their back to seated on the side of their bed.

  20. Tupointo Health – The Helping Hand |Julian Bianco, Mark Perrott, Maggie Lam., Robert Tran, Shehan Wisidagama | Safe patient rolling and holding device for nurses to reduce workplace manual handling injuries.

  21. Aware Care Baby |Clive Kaicer, Jenny Kirschner, Sarah Hunstead, Robert Wise, Jon Seddon | To help parents make informed decisions about their baby’s safety in prams on hot days

  22. DocuMed | Andrew Xu, Gary Chen, Geetika Gupta, Jacky Chen, Sebastian Mensink, Sreshta Sheri | Enables doctors to remind patients of key information from outpatient consultations

  23. Smartheal | Santosh Kaur | SmartHeal allows you to replace paper rulers and dipsticks for wound measurement.

  24. EMR-AI | Taser Zoubi | Leveraging electronic medical records to improve the lives of Australians through the early detection of Osteoporosis.

  25. Kali Healthcare | Emerson Keenan | A digital health platform for pregnancy monitoring to provide better access to care

  26. Shrinker | Omar Ibrahim | Solving the problem any therapy seeker faces, not knowing if their prospective therapist will be a good personal match/fit, through Artificial Intelligence, genetics, and neuroscience

  27. VR for remote mental healthcare support | Shiva Pedram | Provision of mental healthcare through applications of VR for members of remote communities.

  28. Ophthalmoscope | Jacob Cook |  Patient-empowered retina analysis

  29. A-Eye | Mojtaba Golzan | A-Eye is a disruptive technology platform that detects signs of abnormal brain pressure through a simple eye scan

What is next?

The experience culminates in the MedTech Actuator Origin Semi-Finals on 27th October where teams will compete for a place in the MedTech Actuator Showcase. At the Showcase, teams will have the chance to win a share of the $10K prize pool, over $5k worth of in-kind support and gain access to fast-tracked entry into MedTech Actuator Accelerator 2023.

Stay in the loop by signing up for our newsletter below to get the latest updates on our programs and upcoming events.

MedTech Actuator Origin is supported by LaunchVic and the REDI Initiative, powered by MTPConnect. 



MedTech Actuator Origin Alumni: Vause Medical

Vause Medical is making lumbar punctures more accurate and accessible in newborns. Using machine learning and medical imaging, the team are creating LumVi – a guidance system that will help clinicians choose the best point to insert needles during lumbar punctures, increasing accuracy and efficiency of care. This will allow more children to have access to this crucial procedure and medical care, no matter where they are.

Vause Medical’s Origin story

Mara Quach, Shelby Holland, and Michelle Callow, founders of Vause Medical, came together while undertaking the University of Melbourne’s BioDesign Innovation course in 2021. After talking with clinicians, the team identified the recurrent problem of finding accurate puncture points, prevalent across paediatrics and general medical practices. When a newborn is brought to an emergency room with a fever or seizures, chances are they will need to get a test for meningitis, which includes a lumbar puncture where a long needle is inserted into their back. This critical procedure is not only painful, but also difficult to perform on small children, particularly in rural areas with the added costs of equipment, wages, manual labour, and a need for an extra specialist to perform the imaging. With a device like Lumvi, the team aims to streamline lumbar punctures with medical imaging to identify puncture points, taking the guesswork out of difficulty in meningitis diagnoses.

Motivation to improve healthcare accessibility

Healthcare disparities in the team’s respective home countries impacted them directly and drove them to come together to try and create a solution that removes barriers to accessing healthcare. 

For Shelby Holland, financial barriers to healthcare are the motivator: 

As a US citizen, I don’t have access to health insurance as it’s a huge cost for me. Back in 2019 when I went home to visit my family over Christmas, I didn’t have health insurance. I had to go to the hospital for an anaphylactic reaction and I am still paying off those medical bills. There are countless times in my life when I’ve had to make the decision between using my EpiPen and going to the hospital and incurring the costs after,” Shelby Holland.

For Mara Quach, her personal motivation comes from her experience in Vietnam where healthcare resources are limited. 

When I was growing up, I spent a lot of time in hospitals as my mother was really sick. The question to me was how do you distribute a limited amount of resources to 90 million citizens in a country? Experiencing illness and seeing cancer patients not getting access to treatments motivated me to try to make healthcare accessible and adequate for all,” Mara Quach.

After spending significant time working in the pharmaceutical industry, Michelle Callow is inspired to address the biases in healthcare.

I’m very conscious of inequities in health globally. In my current role in the pharmaceutical industry, I see the impact that innovation could have on patient outcomes and equally in remote areas. I am driven by the impact that innovation can have not only on addressing problems in accessing resources but also on the patient and their families,” Michelle Callow.

Their strong support network consisting of the MedTech Actuator, BioDesign Innovation leaders and other startups is driving the team to bring this product to market. 

We want to make our idea work as we want people to live happier, healthier lives and want to make an impact on newborns and their families”.

The MedTech Actuator Origin experience

Before applying to the MedTech Actuator Origin, Vause Medical was undertaking BioDesign Innovation at the University of Melbourne. Having completed the concept designs and early-stage clinical validation, the next step was to develop a prototype and build their network. 

We knew that Origin was a well-respected competition to test out your idea and see what people think about it. So we applied for the program as it ended up being a safe learning environment to validate our theories, pressure test our concept and gain feedback from people that were valuable”, Vause Medical team.

As Vause Medical progressed, they learned innovative ways to design and test the solution to get closer to a prototype and minimum viable product. Other challenges have been finding stakeholders, such as clinicians, to assist with product development and further validation. 

The team utilised the mentoring opportunities in Origin to rework the initial LumVi designs and deepen their connections with the ecosystem. The team also engaged with regulatory consultants, who helped to craft a clear vision of what a LumVi would look like in clinical settings and how this would inform the subsequent regulatory pathway. From here, the team were able to pivot and refine their product strategy and better address a variety of benefits to different stakeholders. 

Don’t try to reinvent the wheel

During ideation, Vause Medical received key advice from mentors early on – don’t try to reinvent the wheel – and this has become their north star. For emerging teams and startups, Vause Medical advises a similar approach; don’t try to change something for the sake of changing something, you must start with a powerful mission statement that addresses a clinical need for a specific user group. 

From an industry perspective, Michelle advises, “Healthcare is a challenging industry to be in because of all the regulations that we have. You should have a real love or connection to what you’re developing and a business or a clinical need”. 

When it comes to taking the first step, Vause Medical recommend reaching out and not being shy when it comes to asking for help from partners, distributors, and manufacturers. There is power in asking for help and you never know where one conversation can lead to.

Mentors and advisors of Vause Medical have been incredible drivers to help progress the team, including: 

  • The BioDesign Innovation lecturers, Prof David Grayden, Prof Kwanghui Lim, and Simon Wilkins, showed the A-Z of identifying a problem that is worth bringing to market. 
  • Yaser Darban, General Manager of Sales Strategy at EnTech Electronics, was their Origin mentor and who inspired them inspiration, shared wisdom and connected the team to other industry partners. 
  • Elise Sutherland, Founder of Stelect, guided them through some of the early-stage unknowns of building a healthcare venture.

Apply for MedTech Actuator Origin 2022

Vause Medical made it to the Semi-finals of MedTech Actuator Origin 2021, helping them to get out of an echo chamber and into the startup ecosystem. The Origin experience connected them with key stakeholders and mentors, enabling them opportunities to stress-test LumVi and dive into their product strategy.

MedTech Actuator Origin is a pre-accelerator for the MedTech Actuator’s Accelerator program. Participants can gain fast-tracked entry into the program and the Winner of Origin receives further mentoring to help address key milestones required for the application. After completing MedTech Actuator Origin, Vause Medical applied and was accepted into the MedTech Actuator Accelerator Cohort 7.

Origin was incredibly beneficial for us, as it gave us that springboard that we needed and the confidence to know that we could progress forward. We are very grateful for the opportunity and are fortunate to join MedTech Actuator Accelerator as the next step. We’re working hard on LumVi, and we’re dedicated to getting it to market”, Michelle Callow.

Whether you’re a researcher, scientist, clinician or student, MedTech Actuator Origin is looking for passionate entrepreneurs to transform healthcare. The winner of MedTech Actuator Origin will receive a $10k cash prize, over $5k worth of in-kind support and gain access to fast-tracked entry into MedTech Actuator Accelerator 2023.

Have questions about the application or program?

Check out the FAQs or reach out to Makenzie, Program and Community Coordinator via email – makenzie@medtechactuator.com – or book a meeting with the team via calendly

MedTech Actuator Origin is supported by LaunchVic and the REDI Initiative, powered by MTPConnect.




Make your MedTech Actuator Origin 2022 application stand out

Thinking about applying to the MedTech Actuator Origin Program? Here are some top tips on how to make your application shine from Shanna Lam – Project Officer at MedTech Actuator.

As a biodesign alumna and an ex-founder I know first-hand how complicated the journey ahead can seem. It does take a village to bring health innovation to market. Luckily, we at MedTech Actuator have done this before and are here to help. Below are a few ideas on how to make your application shine! 

Now that you’ve come up with an innovative health venture and are ready to take the first step to become a startup founder, you might be asking yourself – what’s next?

MedTech Actuator Origin is an early-stage innovation program that turbocharges the development of emerging human health technologies and solutions across Australia and it is the perfect place for emerging founders to start. 

“This is the best first step you can take if you are interested in the MedTech innovation space. The Origin experience will provide you with mentorship, networking and connections. Also, the practical pitching advice you receive will help you in getting further investment or just getting people interested in your idea”, says Wiliam Symington, co-founder of Anura Medical, on his program experience. 

Applications are currently open for the 2022 program and they close on October 7 at 11:59 pm AEST. If you’re excited to join in then you’ll need to nail the application in order to be successfully selected. Below are key areas where you can strengthen your application to put your best foot forward for the program. 

1. Make sure you’re eligible!

First, double-check the eligibility criteria to make sure the program is the right fit for you:

  • You have a research project, idea or innovation in human health;
    • And, for this project, the idea or innovation has to be in its early stages of development;
  • You are highly motivated to learn about innovation commercialisation, as well as Australia’s health, medical and biotechnology startup ecosystem;
  • You are able to attend all program (in-person in Melbourne and online) activities scheduled (Oct 25-27, Dec 1); and,
  • You have at least one team member based in Australia.

2. What is the problem you are trying to solve?

The origin experience will help you better define and develop the elements described below, so don’t worry about having it perfect. 

First, tell us what you know about the problem you are solving, who has this problem, and why you’re motivated to solve it. 

Some of the questions you can think about: 

What are the current hospital workarounds, or the daily impacts it has on the patient? 

Who are the people it affects? It may impact not only the patients, doctors, and hospitals, but also family members, insurance companies, and the government.

Customer Validation

In your applications, we want to see a simple description of your idea with key features and benefits (how the person’s experience will improve).

A good first step would be to figure out who are the users and beneficiaries of your innovation – clinicians, patients, and payers. Next, getting a better understanding of their perceptions about the problem, gaps and potential solutions could be the key to understanding the market.

Below are some thoughts from one of our founders on customer validation.

Tim Tyndale, Quitta:

Customer validation can seem like an inconvenient step that slows the building process. After all, we entrepreneurs know exactly what our customers want already…right?!

In truth, validating the problem and solution is more important in MedTech/BioTech than almost any other field. In a highly regulated industry, the further you go down the development journey, the harder it gets to make adjustments. 

In Quitta’s case, we wanted to tailor our solution to the needs of our end-users without having to conduct expensive clinical trials for each iteration. Fortunately, e-cigarettes created a legal precedent in the U.S. for us to test real-world demand and gain all-important user feedback.

Without developing a deep understanding of the needs of our customers, we could have spent lots of time and money building a product that no one wanted at the other end.

We are not expecting you to conduct dozens of formal customer interviews but we want to make sure you understand how this problem is currently being solved and why your solution would be better. 

3. What is your solution?

Once you’ve validated your problem, now is the time to revisit the solution – what proof do you have that this problem needs to be solved and that your solution will be used? Also, does your solution really address the problem? Has your solution solved one problem but created another? Is it too difficult to adjust to?

Can you communicate this in the most simple terms? You can use the Value Proposition Canvas or The Mom Test to match your solution to the pain points your end users face and communicate this in a concise way.

You can even go back to your customers and see how they react to your solution. Check to make sure your potential customers are not cornered into praising your innovation when you talk to them.

Practical tips for the application:

  • Be concise, don’t use too much technical jargon and tell us how the solution addresses the problem identified.
  • Don’t just tell us how great you think your solution is, tell us who else thinks it’s great, how many people you’ve spoken to and what feedback you’ve received. Back your solution with evidence where possible.

Don’t worry about having it perfect, in the program we will help you better define your problem and solution and learn more about the market. 

4. Passion

Being a startup founder is hard, and can be overwhelming at times. Health ventures could sometimes take years to enter the market and secure a revenue stream, so motivation, focus and a strong support system can’t be underestimated. 

We want to know what drives you to pursue this project, and what does it mean to you? How can we know that you will be committed in the long run? Why are you or your team the right people to take this product to market?

“Challenging the existing market and making the device available to patients is what drives me forward,” says Lorace Zhang, CEO of Vysum. 

Read more about last year’s Origin pitch competition winner, Vysum, and their origin story here

In your application, be sure to tell us:

  • What makes you passionate and committed to this project, innovation or idea?
  • Why you and why your team?

Here to help with your next steps

Applications to MedTech Actuator Origin close on October 7 at 11:59 pm AEST.

If you have any questions, please don’t hesitate to book a call with the team or me.  We’re here to help.

Or, come along to some of our upcoming events:

Starting a company can be overwhelming and exhausting. But they don’t need to be – connection, community and relationships of support are what make the difference. If you decide to join us on the journey, you will be welcomed into our community of 250 MedTech founders and befriend companies like Nutromics, Navi, Ventora, Jay-Nik, and others!

MedTech Actuator Origin is supported by LaunchVic and the REDI Initiative, powered by MTPConnect.



Announcing MedTech Actuator Origin Japan’s semi-finalists

After three days of working closely with 14 medical startups in Japan, MedTech Actuator is excited to announce three semi-finalists who will join MedTech Actuator Origin in Australia in one month. 

MedTech Actuator Origin Japan – an early-stage innovation program for MedTech, BioTech, and HealthTech startups looking to explore Australia and the Asia-Pacific market – kicked off its first cohort this week, welcoming a diverse range of medical and health innovations that spanned across diagnostic imaging, bioprinting, endoscopy, elderly care and cancer treatments and care.

Emerging founders and entrepreneurs joined MedTech Actuator and partners, JETRO, OCCI, OBDA and industry experts, for a 3-day bootcamp in Osaka. Together, explored the medical startup ecosystems across Australia and Asia-Pacific and learned about pitching their innovations to a global market, commercialisation strategies and more. The program culminated at a Semi-final, where each startup pitched for their chance to come to Australia and join MedTech Actuator Origin in October.

Congratulations to Osaka Heat Cool, Relive and iDevice,Inc.

Judges and industry guests were blown away by the medical innovations and quality of each pitch. Congratulations to the selected semi-finalists:

  • Osaka Heat Cool (Thermo Scratch) | Kenzo Ibano | Osaka Heat Cool helps to tackle the symptoms of Atopic Dermatitis(AD), allergies, and other skin diseases by stopping itchiness using thermal illusion on the skin.
  • Relive (CureMind) | Risa Kaneda,Iizuka Sora, Kubo Tokumi  | CureMind is an online, high-availability, real-time access to cancer support services in a safe environment via a mobile application.
  • iDevice, Inc. | Yuto Kido |  iDevice has created the Javalla mask – a tailor-made ventilation mask that provides comfortable sealing and prevents skin injuries and discomfort.

Next, these Japanese startups will join MedTech Actuator in Melbourne next month for a week-long intensive program, where over five days they’ll learn from industry experts, pressure test their innovations, and network with and pitch to Australia’s startup ecosystem. 

Ultimately, one Japanese startup will be selected to return to Australia to pitch at the MedTech Actuator Showcase – an industry event attended by 300 experts in BioMedical innovation on December 1. At this event, startups will compete for a chance to win a $10K cash prize, over $5k worth of in-kind support, and a fast-tracked entry into MedTech Actuator Accelerator 2023  to accelerate the commercialisation of their ideas.

MedTech Actuator Origin Japan is sponsored by JETRO and co-organized with JETRO, OCCI and OBDA.

Applications are now open for MedTech Actuator Origin Australia 2022 

Do you have an idea, project or innovation in human health? Located in Australia? Find out more about MedTech Actuator Origin and apply today.

Stay in the loop by signing up for news and updates below.

You can also follow us on LinkedIn, Twitter, Facebook and Instagram to keep up to date with the latest events and programs.




MedTech Actuator Origin Alumni: Vysum

Vysum is developing an eye drop delivery device to make administration more convenient, comfortable and accurate for all, starting with glaucoma eye drop users. Vysum’s solution also supports clinicians to make more informed decisions by providing compliance data on eye drop administration.

Vysum’s Origin story

The idea for Vysum originated from the University of Melbourne’s BioDesign Innovation course, where the team came together in 2021. The team comprises members from diverse backgrounds, with Lorace Zhang, CEO, bringing a scientific background (Biomedical engineering) and is joined by business-driven co-founders David Lin and Isaac Ho. Together, the team is united by their passion to improve the lives of patients suffering from glaucoma.

The team was determined to address an unmet clinical need and interviewing multiple clinicians and ophthalmologists highlighted the struggles of treatment compliance of glaucoma patients. Speaking with hundreds of patients unveiled the scale of this clinical problem, with many patients failing to adhere to treatment plans due to difficulty administering eye drops. At this point, the idea for an eye drop administration device was born to improve health outcomes for glaucoma patients. 

The team in its early days working on the idea for Vysum

Improving clinical outcomes of glaucoma patients and enabling a more positive lifestyle with the use of their device is the team’s mission. For patients with glaucoma, adherence to the treatment regime means preventing blindness. 

“There are devices that can aid in eye drop delivery, listed on 510K database, that date back to 1985. But the problem is still unsolved as these devices are not addressing the core of the problem: the difficulty of administration AND compliance, which is now self-reported by patients. We believe that accurate compliance data will help clinicians make more informed treatment decisions. Challenging the existing market and making the device available to patients is what drives me forward,” says Lorace Zhang, CEO of Vysum.

The journey from BioMedical Student to CEO

Lorace has embraced the transition from student to CEO, jumping out of her comfort zone and into the startup ecosystem, both a challenging and rewarding leap. For the team the biggest learnings came from engaging with the startup ecosystem through programs like MedTech Actuator Origin, industry mentoring, networking events and pitching competitions which allowed the team to establish connections across the ecosystem.

We are living through a new ‘Age of Innovation’ in health. From new diagnostics and devices to new cancer treatments and HIV interventions; from new insights in genomics and data analytics to new wearables that empower people in respect of their own health and wellbeing. It all starts with passion and a desire to create a real impact on society. Whatever the pursuit, superhero entrepreneurs – like Lorace – are out to change the world and advance healthcare for all of us”. Dr Buzz Palmer, CEO and Co-founder of MedTech Actuator.

The MedTech Actuator Origin experience

Before applying to MedTech Actuator Origin, Vysum had just completed BioDesign Innovation and was driven to maintain momentum, learn more about the MedTech ecosystem, build a strong network and tackle the next milestones in their journey. 

Through MedTech Actuator Origin, participants had a chance to pitch their innovation to the industry over multiple rounds and be selected for the MedTech Actuator Showcase – the Origin Final. With a strong pitch led by Lorace, Vysum took home the top prize as the winner of the Johnson & Johnson MedTech Actuator Origin Award 2021

With a cash prize, mentoring and support from the MedTech Actuator, Vysum received an opportunity to collaborate with product development companies. This led them to meet their mentor, Paul Carboon from Outerspace, and to continue to refine their product development goals and design and usability of the device.

Through networking opportunities, Vysum also engaged with MedTech Actuator’s foundational partner FB Rice to file a provisional patent and secure the intellectual property behind their innovation. 

MedTech Actuator Origin is a pre-accelerator for MedTech Actuator’s Accelerator program. Participants can gain fast-tracked entry into the program and the Winner of Origin receives further mentoring to help address key milestones required for the application. After completing MedTech Actuator Origin, Vysum received this valuable support and successfully applied and was accepted into the MedTech Actuator Accelerator’s  Cohort 7.

After completing Origin, Accelerator did almost feel like the natural step. While Origin gave us the first, official public acknowledgement of our work and vision, joining the Accelerator would give us the exposure and guidance we needed next,” says Lorace Zhang, CEO of Vysum.

Vysum, Winner of the Johnson & Johnson MedTech Actuator Origin Award 2021 at the MedTech Actuator Showcase.

The most beneficial aspects of MedTech Actuator are the exposure to the public, to the industry, and partners in the ecosystem. This helped us to validate our idea, receive public acknowledgement of what we were building and take home the cash prize, which is all very encouraging”, says Lorace Zhang, CEO of Vysum.

MedTech Actuator provides mentoring and networking opportunities to participants across all programs. Vysum is grateful to have the following mentors support their startup journey:

  • Jonathan Crowston, a renowned ophthalmologist and a glaucoma specialist, helped Vysum better understand the industry workflow and clinical requirements. 
  • An external clinical advisor, well connected to clinicians, patients and the industry, has provided clinical advice and helped to strengthen the business model.
  • Stephen Ho has been generously providing guidance on corporate governance, business case and company structure and helping the team grow.
  • Clinical advisors and lecturers of the BioDesign course, Kwanghui Lim, Simon Wilkins, and David Grayden, played pivotal roles in the team’s journey. 

Apply for MedTech Actuator Origin 2022

Are you on a similar journey to Vysum? Have an idea in its early stages that you’re interested in commercialising? Applications are open for MedTech Actuator Origin 2022 until October 7 at 11:59 pm.

“You can’t lose anything by joining Origin – but you gain a chance to win everything from cash prizes to connections, and it is a great learning opportunity! I was not a forward-facing person initially and would never have become the face of Vysum, but Origin forced me into the spotlight and encouraged me to start exploring what the founder’s life could be like”, says Lorace Zhang, CEO of Vysum.

Whether you’re a researcher, scientist, clinician or student, MedTech Actuator Origin is looking for passionate entrepreneurs to transform healthcare. The winner of MedTech Actuator Origin will receive a $10k cash prize, over $5k worth of in-kind support and gain access to fast-tracked entry into MedTech Actuator Accelerator 2023.

Have questions about the application or program?

Check out the FAQs or reach out to Makenzie, Program and Community Coordinator via email – makenzie@medtechactuator.com – or book a meeting with the team via calendly

MedTech Actuator Origin is supported by LaunchVic and the REDI Initiative, powered by MTPConnect.





Announcing MedTech Actuator’s first Origin Japan cohort

MedTech Actuator is proud to announce its early-stage innovation program, MedTech Actuator Origin Japan 2022, launching next week.

This program supports health innovation across Japan, offering emerging founders and entrepreneurs the opportunity to explore the Asia-Pacific market for the commercialisation of health innovation. 

The selected top 14 Japanese MedTech, BioTech and HealthTech entrepreneurs will start the program with MedTech Actuator, JETRO (Japanese External Trade Organisation), OCCI (Osaka Chamber of Commerce and Industry), OBDA (Osaka Business Development Agency) and industry experts from across Japan and Australia, at a 3-day bootcamp in Osaka next week. Together, they will learn about the Asia-Pacific ecosystem, pathways to market, startup investment cycles, strategic partnerships and attend a series of pitching workshops before pitching for their chance to travel to Australia to join MedTech Actuator Origin.

Welcoming Origin Japan participants

We are excited to announce the 14 teams selected to participate in the MedTech Actuator Origin Japan 2022 Program. 

  • Smart Tissues Co., Ltd. | Kohei Katsurasako, Denise Zujur | Smart Tissues Co. is developing the first antibacterial and universal bioink for bioprinting human living tissues and organs.
  • Osaka Heat Cool (Thermo Scratch) | Kenzo Ibano | Osaka Heat Cool helps to tackle the symptoms of Atopic Dermatitis(AD), allergies, and other skin diseases by stopping itchiness using thermal illusion on the skin.
  • Second Heart project | Yukihiro Ishida | Second Heart project is developing a healthcare device that allows easy observation of the feet in the home to prevent amputation due to diabetes.
  • Medical Shinansha | Kosuke Sasai | Medical Shinansha provides a suite of diagnostic imaging innovations that support clinician navigation and student training to lead to more efficient clinical management, improved patient satisfaction, and better clinical capacity for accurate diagnosis.
  • Chinougijutsu Co., Ltd. | Ryoji Otsu, Seiichi Hayashi |  Chinougijutsu Co. has jointly developed an artificial intelligence system that prevents falls in hospitals and aged-care settings.
  • RealVision | Gajanan Revankar | A digital therapeutic and diagnostic tool for neurodegenerative diseases that improves diagnosis, prognosis, and long-term disease management.
  • PMCODE Co., Ltd. | Tatsuya ONODA, Masatoshi Taketani | A hybrid information storage symbol mark technology for patient-driven healthcare information management.
  • Tombo™ Systems KK | Ross K. Purdie, Michael Clemons | The Tombo is a certified non-exercise, thermo-genesis activity device that prevents the onset of deep vein thrombosis from sitting at a chair or in front of a computer for a long period of time.
  • MediGear International Corporation | Takeo Tanaka |  A drug-free tumour-targeted minimally invasive therapy” that obtains an antitumor effect without a drug by blocking the supply of oxygen and nutrients to cancer cells by locally administering a uniquely developed nanodevice to the tumour and specifically surrounding the tumour as a barrier.
  • Relive (CureMind) | Risa Kaneda | CureMind is an online, high-availability, real-time access to cancer support services in a safe environment via a mobile application.
  • Kyocare | Hiba Abuelgasim Fadlelmoula Abdelrahman | A digital platform connecting families with elderly relations in need of care to care workers from their local community.
  • Mu Ltd. (MiniMermaid) | Naotake Ohtsuka, Hirosuke Tomozoe |  Mu is developing Minimermaid, a self-propelled capsule endoscopy for the examination of digestive tract cancer without pain.
  • Redge, inc. | ​​Takahiro Hirayama | Redge is developing CeTrax, a medical device management and education system that leverages Japanese clinical engineering technology to address the lack of reliable information and training.
  • iDevice, Inc. | Yuto Kido |  iDevice has created the Javalla mask – a tailor-made ventilation mask that provides comfortable sealing and prevents skin injuries and discomfort.

Congratulations to the qualifying teams. We wish them all the best with their pitches at the Origin Japan semi-final on Wednesday.

Next, the 3 qualifying teams from Japan will join MedTech Actuator in Melbourne in October where over five days they’ll learn from industry experts, pressure test their innovations, and network with and pitch to Australia’s startup ecosystem. 

Ultimately, one Japanese startup will be selected to return to Australia to pitch at the MedTech Actuator Showcase 2022 – an industry event attended by 300 experts in health innovation on December 1. At this event, startups will compete for a chance to win a $10K cash prize, over $5k worth of in-kind support, and a fast-tracked entry into MedTech Actuator Accelerator 2023  to catalyse the commercialisation of their ideas.

MedTech Actuator Origin Japan is sponsored by JETRO and co-organized with JETRO, OCCI and OBDA.

Applications are now open for MedTech Actuator Origin Australia 2022 

Do you have an idea, project or innovation in human health? Located in Australia? Find out more about MedTech Actuator Origin and apply today.

Stay in the loop by signing up for news and updates below.

You can also follow us on LinkedIn, Twitter, Facebook and Instagram to keep up to date with the latest events and programs.



MedTech Actuator Origin Alumni: Anura Medical

Anura Medical is developing a wearable patch that continuously monitors lung function to detect lung decline, promote early treatment and improve overall health for people with respiratory disease.

The Origin Story

Anura Medical came together in 2021 through the University of Melbourne’s BioDesign Innovation course as a team of Melbourne Business School and Biomedical engineering students. The team has diverse experience in clinical medical practice, supply chain consulting, biomedical and mechanical engineering. The three team members aligned across backgrounds and outlooks on the problems to be solved in the healthcare ecosystem and started working on Cahm, a respiratory monitoring device.

The idea for the device originated when Dr Rebecca McCormick and Co-Founders, Phoebe Lewis and Wiliam Symington, identified the issue that monitoring lung health for people with flare-ups of chronic lung disease requires invasive blood tests, which can lead to delayed treatment. After speaking with clinicians across various fields for 3 months, this unmet clinical need stood out to the group.  Through this process, multiple clinicians cited the healthcare ecosystem was desperate for a better way to monitor ventilation and response to treatment, rather than the intermittent current standard.

“I have spent 6 years working in hospitals as a medical doctor and have experienced the challenges faced by physicians and patients in respiratory medicine.  The technology currently available means that monitoring practices are reactive, as they rely on patients displaying signs or symptoms first. I believe that there is a better way of preventing complications through non-invasive monitoring of high-risk patients. Technology that supports preventative medicine is the way of the future”, says Dr Rebecca McCormick

The Anura Medical team is driven to improve respiratory monitoring ability for clinicians and patients who are at a higher risk of respiratory diseases and the complications associated.

Origin team with their first prototype: William Symington, Rebecca McCormick, Jessica Anderson, Phoebe Lewis and Ela Venugopal.

The MedTech Actuator Origin experience 

After identifying their unmet clinical need and developing their solution, Anura Medical set the goal to get into MedTech Actuator Origin in 2021. MedTech Actuator Origin is an early-stage innovation program for emerging human health technologies and solutions across Australia and would be the first opportunity for the team to test their concept outside of the Biodesign classroom.

“The program is a good way to pressure test your idea, as this was our first time testing our concept outside of the university environment,” says Dr Rebecca McCormick.

MedTech Actuator Origin provides founders with the opportunity to validate their idea with the industry and pitch them to the startup ecosystem, often for the first time. Selected teams join MedTech Actuator in Melbourne for an intensive sprint, where, over three days, they learn to work alongside 20 other teams from Australia and Japan and pitch for their chance to win a $10k cash prize, over $5k worth of in-kind support and gain access to fast-tracked entry into the MedTech Actuator Accelerator 2023. 

“This is the best first step you can take if you are interested in the MedTech innovation space. The Origin experience will provide you with mentorship, networking and connections. Also, the practical pitching advice you receive will help you in getting further investment or just getting people interested in your idea”, says William on his program experience. 

Overcoming challenges with determination

Motivated to make a bigger impact on patients through innovative medical technology, the biggest challenge for the Anura Medial team had been to move from ideation and validation in the clinical setting to the startup world and address key risks involved in the early days of launching a company. It included shifting gears and focusing their efforts on key tasks to maintain their current trajectory to get to the market.

I think one challenge is just the amount of moving parts and trying to understand all the intricacies of all of those different things that you have to be aware of when you’re trying to start a medical device venture. It’s not just the technology, it’s everything else that comes with that”, says Phoebe.

Phoebe, and William with mentor Stephen Ho when they won the ‘Stephen Ho Innovation Award’ with significant funding to help them commercialise their project idea.

This is where MedTech Actuator Origin proved to be highly valuable. Through the program, emerging entrepreneurs get an opportunity to validate, pressure test and turbocharge their project turning it into an early-stage startup.

Along with the Origin experience, mentors and advisors have played an important role in Anura Medical’s progress, helping them think holistically about the pathway forward. Among those, Kwanghui Lim, David Grayden and Simon Wilkins from BioDesign Innovation, along with their advisor Stephen Ho, have been instrumental in shaping the team and product capabilities at the early stages. 

One of the team’s biggest tips to emerging founders and entrepreneurs is to choose the right team with diverse skills where members get along and challenge each other. This is what Anura Medical credits for bringing the best out in each other across the journey to date.

Since their time in MedTech Actuator Origin, where the team received its initial validation, Anura Medical has been set up as a company in May 2022 and continues on the pathway to market as part of the MedTech Actuator Accelerator 2022 cohort. The team has secured its first early-stage funding through the Accelerator and is working towards a functional MVP.

“It is a good introduction into the MedTech world, as you get involved with people in the same circle”, says Phoebe on the beneficial aspects of being an Origin participant.

Apply for MedTech Actuator Origin 2022

On a similar path as Anura Medical? Applications are now open for the MedTech Actuator Origin 2022.

Whether you’re a researcher, scientist, clinician or student, MedTech Actuator Origin is looking for passionate entrepreneurs to transform healthcare. The winner of MedTech Actuator Origin will receive a $10k cash prize, over $5k worth of in-kind support and gain access to fast-tracked entry into MedTech Actuator Accelerator 2023.

Have questions about the application or program?

Check out the FAQs or register for the upcoming information session about the MedTech Actuator Origin 2022.

MedTech Actuator Origin is supported by LaunchVic and the REDI Initiative, powered by MTPConnect.